L&C Bio Co. Ltd Cash Flow Reinvestment Rate

Latest as of September 2025: 1.61x

L&C Bio Co. Ltd cash flow reinvestment rate. L&C Bio Co. Ltd (290650) has a Cash Flow Reinvestment Rate of 1.61x as of September 2025, reinvesting ₩6.11 Billion (capex ₩3.10 Billion plus investments ₩-3.01 Billion) from operating cash flow of ₩3.79 Billion. See financial flexibility index of L&C Bio Co. Ltd to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

1.61x
(Capex + Investments) / Operating CF

Total Reinvested

₩6.11 Billion
Capex + Investments

Operating Cash Flow

₩3.79 Billion
KRW

Capital Expenditures

₩3.10 Billion
KRW

Cash Flow Reinvestment Rate of L&C Bio Co. Ltd (2017–2021)

Cash flow reinvestment rate of L&C Bio Co. Ltd from 2017 to 2021. Historical reinvestment intensity for L&C Bio Co. Ltd across 5 annual periods. Explore L&C Bio Co. Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

L&C Bio Co. Ltd Cash Flow Reinvestment Rate by Year (2017–2021)

L&C Bio Co. Ltd cash flow reinvestment rate by year from 2017 to 2021. Year-by-year capital reinvestment analysis for L&C Bio Co. Ltd. For the full cash flow conversion analysis, see cash flow conversion of L&C Bio Co. Ltd.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2021 1.51x ₩16.49 Billion ₩10.91 Billion ₩10.25 Billion ▲ +70.2%
2020 0.89x ₩6.59 Billion ₩7.42 Billion ₩3.02 Billion ▼ -60.7%
2019 2.26x ₩14.53 Billion ₩6.43 Billion ₩1.96 Billion ▼ -45.6%
2018 4.15x ₩15.96 Billion ₩3.85 Billion ₩4.74 Billion ▲ +3954.1%
2017 0.10x ₩390.87 Million ₩3.82 Billion ₩285.34 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow